Drug Topics
JULY 23, 2024
A survey conducted by Surescripts, a health care solutions company, explored the attitudes of pharmacists and prescribers towards ongoing issues and challenges currently facing the industry.
Pharmacy Is Right For Me
JULY 23, 2024
Hey there, future pharmacists! I’m Shelby, a student pharmacist at the University of Findlay (UF), and I’m here to share my journey with you. If you’re thinking about a career in pharmacy or just curious about what it’s like, you’re in the right place! Falling in Love with Findlay My adventure started the summer before my senior year of high school at Findlay’s Summer Pharmacy Camp.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
JULY 23, 2024
BARDA director Gary Disbrow explains the agency’s focus, how companies can get their “foot in the door” and why platforms are so important for preparedness.
Pharmacy Times
JULY 25, 2024
Pharmacists could play a major role in answering patient questions and providing counseling about cannabis
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 25, 2024
The American College of Allergy, Asthma, and Immunology (ACAAI) recently released its 5 tips to help children and their parents stay educated on asthma peak month.
STAT
JULY 25, 2024
UnitedHealth Group started out as a small, Minnesota health insurance company and has since morphed into a modern-day Standard Oil, exerting unmatched dominance over health care in the United States. It’s no secret that UnitedHealth is a colossus: It’s the country’s largest health insurer and the fourth-largest company of any type by revenue, just behind Apple.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JULY 24, 2024
The decision offers patients with difficulty swallowing their medication expanded options for treatment administration.
Drug Topics
JULY 22, 2024
Researchers aimed to determine the risks and benefits of prescription drug advertising released in tandem with disease awareness programming.
STAT
JULY 23, 2024
CVS Caremark, one of the largest pharmacy benefit managers in the country, agreed to pay at least $45 million to the state of Illinois to settle allegations that rebates were not passed through during a recent four-year period, according to a document obtained by STAT. At issue is a complicated, behind-the-scenes relationship between the PBM and several related entities — in particular, a so-called group purchasing organization — that allegedly obscured rebates paid by drug manufac
PharmaVoice
JULY 22, 2024
With great potential in cell and gene therapies, there are still plenty of barriers to getting the breakthroughs to patients.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 26, 2024
The investigational drug achieved non-inferiority compared to routine Factor VIII.
Drug Topics
JULY 23, 2024
MK-1654 (clesrovimab) met its primary efficacy endpoint of incidence of patients with RSV-associated medically attended lower respiratory infections (MALRI) through Day 150.
STAT
JULY 22, 2024
Express Scripts, one of the largest pharmacy benefit managers in the country, overcharged U.S. Postal Service employees by a whopping $45 million for their prescription drugs during a recent five-year period, according to a federal audit. The findings are likely to intensify scrutiny of the controversial role played by PBMs in the opaque pharmaceutical pricing system.
Fierce Healthcare
JULY 25, 2024
Humana inked a new multi-year agreement with Google Cloud to modernize its cloud infrastructure and build out generative AI solutions. | Humana inked a new multi-year agreement with Google Cloud to modernize its cloud infrastructure and build out generative AI solutions.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JULY 25, 2024
Adherence and efficacy were both higher in patients with HIV who took twice-yearly lenacapavir compared to those on oral preexposure prophylaxis medication.
Drug Topics
JULY 26, 2024
Check out these important FDA updates from the month of July 2024.
STAT
JULY 22, 2024
Bird flu snapshot: This is the latest installment in a series of regular updates on H5N1 avian flu that STAT is publishing on Monday mornings. To read future updates, you can also subscribe to STAT’s Morning Rounds newsletter. Public health experts who’ve been following the surprising spillover of H5N1 bird flu into America’s dairy cattle herds now have all eyes on Colorado, waiting to see if a cluster of human cases there might balloon into something bigger.
Pharmaceutical Technology
JULY 22, 2024
As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JULY 25, 2024
Despite the century-long period of virus evolution, 6 of the 11 primates that received a cytomegalovirus-expressed flu vaccine survived the exposure to H5N1 flu.
Drug Topics
JULY 24, 2024
PASO DOBLE is the largest head-to-head, phase 4 randomized clinical trial comparing DTG/3TC and BIC/FTC/TAF in patients with HIV.
STAT
JULY 23, 2024
Following the release of widely touted study results for a Gilead Sciences HIV treatment, a new analysis finds the medicine — called lenacapavir — could be made for as little as $26 to $40 per person each year, which the researchers argue could alleviate concerns about limited access in many countries. The medicine drew considerable attention last month after a late-stage clinical trial found that twice-a-year injections completely protected cisgender women from contracting HIV.
Fierce Healthcare
JULY 23, 2024
An analysis by Fierce Healthcare identified the top 30 healthcare organizations that burned through the most cash lobbying Congress for healthcare policy changes in the second quarter. | In the second quarter, 14 healthcare organizations spent more than a million dollars lobbying the federal government for healthcare policy change. The leaders of the pack were the American Hospital Association, AARP and the American Medical Association, followed by a slew of payers.
Pharmacy Times
JULY 22, 2024
Eculizumab-aagh does not have an interchangeable designation, though that could be updated in the future.
Drug Topics
JULY 26, 2024
Researchers aimed to address the associations between prenatal cannabis use and maternal health outcomes over a 9-year period.
STAT
JULY 23, 2024
Jeffrey Shuren, longtime chief regulator of medical devices at the Food and Drug Administration, announced to staff on Tuesday that he is leaving the agency, according to six sources and an email reviewed by STAT. Shuren, who spent 28 years at the agency, started his FDA career in the Commissioner’s Office in 1998. He became director of the Center for Devices and Radiological Health in 2009 and has served in that position ever since.
Fierce Healthcare
JULY 23, 2024
Lawmakers bashed the business practices of pharmacy benefit managers during a House Committee on Oversight and Accountability hearing Tuesday. | A contentious hearing between PBM CEOs and the House Commitee on Oversight and Accountability reinforced recent federal angst toward pharmacy benefit managers, but little new ground was made.
Pharmacy Times
JULY 23, 2024
A 5:2 intermittent fasting plan combined with meal replacement had better positive outcomes compared with metformin and empagliflozin.
Drug Topics
JULY 25, 2024
Galderma said the FDA has accepted the company’s Biologics License Application for the therapy based on data from the trials.
STAT
JULY 23, 2024
Medicare and Medicaid are facing a familiar quandary: how to provide coverage for new weight loss drugs with price tags that could effectively bankrupt the federal government’s health care budget while simultaneously ensuring continuous coverage for all other health care services used by millions of Americans. The Centers for Medicare and Medicaid Services announced in March 2024 that it would cover Wegovy (semaglutide), a new and expensive weight loss medication, for beneficiaries with c
PharmaVoice
JULY 25, 2024
A VC investor shares how the market is recovering, which kinds of companies he’s hunting for and where he’d love to see more innovation.
Pharmacy Times
JULY 24, 2024
Studies show an increased prevalence of autism spectrum disorder in children of mothers; mouse models have shown links between maternal asthma and altered behavior and brain function.
Drug Topics
JULY 24, 2024
Full efficacy and safety results for the phase 3 PURPOSE 1 trial were announced by Gilead at AIDS 2024.
STAT
JULY 22, 2024
It seems like organized chaos. Five lab members move around a room the size of a galley kitchen. On this day, three high school students also squeeze into the medical lab, closely peering at a pig heart barely beating in a box. Tubes connected to the heart from a rhythmic, speaker-like pump push warm red blood cells through its chambers. It looks like a scene out of Frankenstein.
Expert insights. Personalized for you.
528 
Let's personalize your content